shRNA-mediated silencing of TARBP2 inhibits NCI-H1299 non-small cell lung cancer cell invasion and migration via the JNK/STAT3/AKT pathway.

Bibliographic Details
Title: shRNA-mediated silencing of TARBP2 inhibits NCI-H1299 non-small cell lung cancer cell invasion and migration via the JNK/STAT3/AKT pathway.
Authors: YUE SHI1 tjshiyue6688@sina.com, DUO ZUO1, XIA WANG2, MENG HAN3, YAN WU4
Source: Molecular Medicine Reports. Oct2016, Vol. 14 Issue 4, p3725-3730. 6p.
Subject Terms: *RNA-binding proteins, *CELL migration, *JAK-STAT pathway, *HIV, *WESTERN immunoblotting, *POLYMERASE chain reaction, *AMYLOID beta-protein precursor
Abstract: Metastasis is a major cause of lung cancer-associated mortality. The current study aimed to investigate the effects and mechanisms of TAR (human immunodeficiency virus 1) RNA binding protein 2 (TARBP2) in the invasion and migration of non-small cell lung cancer in vitro. The highly metastatic cell clone H1299/M02 was obtained by TARBP2 overexpression. Expression of TARBP2 in H1299/M02 was also downregulated to different levels via small hairpin RNAs (shRNAs). Subsequent to TARBP2 silencing, the proliferation of H1299/M02 cells was predominantly unaffected, while invasion and migration were significantly inhibited. A positive correlation was observed between invasion and migration and the level of TARBP2 silencing in vitro. Western blotting and reverse transcription-quantitative polymerase chain reaction indicated that the protein expression levels of amyloid β (A4) precursor protein (APP) and zinc finger protein 395 (ZNF395) were upregulated, while expression levels of pro-metastatic proteins including interleukin (IL)-1β, IL-8, cyclooxygenase (COX)-2, matrix metalloproteinase 2 (MMP2) and MMP9 were downregulated. Phosphorylation of c-Jun N-terminal kinase (JNK), signal transducer and activator of transcription 3 (STAT3) and protein kinase B (AKT) were also inhibited. Overexpression of TARBP2 was suggested to be involved in the metastasis of H1299/M02 cells. Silencing of TARBP2 was able to upregulate levels of APP and ZNF395, in addition to inhibiting metastasis-promoting cytokines, the JNK/STAT3/AKT pathway and COX-2 to attenuate the invasion and migration of cancer cells. [ABSTRACT FROM AUTHOR]
Copyright of Molecular Medicine Reports is the property of Spandidos Publications UK Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:17912997
DOI:10.3892/mmr.2016.5723
Published in:Molecular Medicine Reports
Language:English